Trial Information

Summary: SHINGLES VACCINE

ZOSTAVAX™, a vaccine for the prevention of shingles (herpes zoster), is approved for individuals 60 years of age or older. Clinical Research Associates is one of the selected centers participating in a multi-center investigational study evaluating ZOSTAVAX™.

The purpose of this study is to accumulate additional safety data on the administration of ZOSTAVAX™ in subjects 60 years of age or older.

There is one office visit followed by 3 phone calls during the next 6 months. To qualify, individuals must be 60 years of age or older and be relatively healthy. Compensation is available for time and travel.

For additional information about this research study, visit our website at www.clinicalresearchassociates.com or contact:

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 17, 2008 at 2:51:58 PM